Managing Decentered Aspheric IOLs
Does a significantly decentered aspheric IOL cause more visual disability than a traditional monofocal IOL with equivalent decentration? How do you manage this scenario?
GEORGE BEIKO, BM, BCH, FRCSC
Significant decentration of an IOL is a rare event. When significant tilt and decentration occur, they are usually due to surgery complicated by capsular rupture, inadequate 360° overlap of the anterior capsule on the optic, the IOL's placement in the sulcus, compromised zonules, or ophthalmic trauma. Bench top studies using polychromatic light showed that aspheric lenses need to be decentered more than 0.8 mm or tilted more than 10° before they lose their optical advantage over traditional lenses.1 A meta-analysis of prior studies found that this degree of decentration occurs six times out of 10,000 and that this degree of tilt occurs one time out of 10,0002; so, it is truly rare. More importantly, it has been reported that the single-piece acrylic Tecnis IOL (Advanced Medical Optics, Inc., Santa Ana, CA) design takes a location in the capsule that mimics the natural horizontal and vertical tilt and decentration of young phakic eyes3; thus, a rare event should be even rarer. Patients with decentered IOLs typically complain of decreased vision, polyopia, edge-related glare, or quivering vision.
My experience has been that the symptoms are similar with both aspheric and traditional lenses; I have not found that one is worse than the other. I manage these cases by repositioning and stabilizing the decentered lens; suturing it to the iris, lens capsule, or sulcus; or replacing the lens and stabilizing it via these strategies. My current IOL preference is the Tecnis single-piece acrylic IOL in routine cases and the Tecnis three-piece acrylic IOL (Advanced Medical Optics, Inc.) in complicated cases.
SAMUEL MASKET, MD
The corollary to this question is whether patients discern a clinically significant difference between spherical and aspheric IOLs. Although we measure a reduction in higher-order aberrations (spherical aberration) with aspheric IOLs under certain lighting conditions, patients do not seem to recognize a clinical difference between the vision of an eye that has an aspheric IOL and that of a fellow eye that has a spherical implant. Nevertheless, a significantly decentered IOL, especially an aspheric IOL, will reduce vision and induce symptoms if it is sufficiently off axis. Naturally, the degree of disturbance will vary with the degree of asphericity and eccentricity. Of course, any IOL, when decentered, is apt to produce undesired optical consequences, varying with pupillary size. I would manage a decentered three-piece IOL by bringing the optic into the ciliary sulcus and suturing it to the iris to maintain its positioning and stability. Depending on the cause of a single-piece IOL's decentration, I would place a three-piece IOL in the sulcus and suture it to the iris.
STEVEN G. SAFRAN, MD
Most of what we know about how decentration affects an aspheric IOL is theoretical rather than based on observation. In terms of perfectly centered IOLs, I have found it difficult or impossible to discern a difference between aspheric and standard monofocal IOLs in almost all patients in whom I have placed an aspheric in one eye and a standard implant in the other eye.
The problem with studying decentration is that it is relatively rare, unique, and unilateral. Nevertheless, my clinical impression is that the decentration of most monofocal implants is relatively well tolerated as long as the edge of the IOL does not cause glare symptoms and the refractive change or induced prism is managed with glasses adjustment. On the other hand, I do believe that a decentered aspheric IOL with negative spherical aberration (eg, Tecnis or AcrySof IQ [Alcon Laboratories, Inc., Fort Worth, TX]) will perform less effectively compared with a similarly decentered monofocal implant. Anecdotally, I have seen a few eyes that had aspheric lenses with relatively small decentrations that I felt created problems that would not be as obvious in a similar type of case involving a monofocal implant. I am quicker to offer a repositioning or exchange as a solution to vague symptomatology in the case of mild decentration involving an aspheric IOL.
JEFFREY WHITMAN, MD
Aspheric IOLs are fairly user friendly in terms of decentration. As a general rule, decentration is less of an issue with a neutral aspheric such as the Sofport LI61AO IOL (Bausch & Lomb, Rochester, NY). Aspheric IOLs have the advantage of matching the appropriate negative or neutral spherical aberration to the patient's wavefront measurement when needed. Decentration is more touchy with an aspheric IOL that adds negative spherical aberration, such as the Acrysof IQ monofocal aspheric IOL (SN60WF; Alcon Laboratories, Inc.) and the Tecnis IOL. Decentered spherical IOLs can also cause significant problems, because the power at the center is different than the power in the intermediate and peripheral areas. I base my intervention on the patient's symptoms. I reposition the IOL if the patient is experiencing optical distortion or sees halos and glare.
Section editor John F. Doane, MD, is in private practice with Discover Vision Centers in Kansas City, Missouri, and he is Clinical Assistant Professor for the Department of Ophthalmology, Kansas University Medical Center. Dr. Doane may be reached at (816) 478-1230; email@example.com.
George Beiko, BM, BCh, FRCSC, is Assistant Professor of Ophthalmology at McMaster University, a lecturer at the University of Toronto, and a private practitioner in St. Catharine's, Ontario, Canada. He receives research support from Advanced Medical Optics, Inc., Lenstec,Inc., and Visiogen, Inc. Dr. Beiko may be reached at (905) 687-8322; firstname.lastname@example.org.
Samuel Masket, MD, is in private practice in Century City, California, and is Clinical Professor of Ophthalmology at the UCLA Geffen School of Medicine, Jules Stein Eye Institute, Los Angeles. He is a consultant to Alcon Laboratories, Inc. Dr. Masket may be reached at (310) 229-1220; email@example.com.
Steven G. Safran, MD, is in private practice in Lawrenceville, New Jersey, and he is on staff at the New Jersey Surgery Center, Capital Health System, Robert Wood Johnson University Hospital at Hamilton. He is a speaker for Bausch & Lomb and Heidelberg Engineering GmbH. Dr. Safran may be reached at (609) 896-3931; firstname.lastname@example.org.
Jeffrey Whitman, MD, is President and Chief Surgeon of the Key-Whitman Eye Center in Dallas. He is a consultant to Bausch & Lomb. Dr. Whitman may be reached at (866) 605-4455; email@example.com.
TOP 5 ARTICLES FROM 2009
- Scientific Design of the AcrySof IQ IOL
Details from the inventors of this aspheric IOL.
By Xin Hong, PhD; Stephen J. Van Noy; Dan Stanley; Xiaoxiao Zhang, PhD; and Mutlu Karakelle, PhD
- Expectations for Corneal Collagen Cross-Linking
By A. John Kanellopoulos, MD; Thomas Kohnen, MD; and R. Doyle Stulting, MD, PhD
- Intense, Pulsed Light for Dry Eye Syndrome
The light acts as a warm compress that liquifies the meibomian gland's secretions and ultimately unplugs them.
By Rolando Toyos, MD
- The Boston Keratoprosthesis
An update on recent advances.
By Michael A. Klufas, ScB, and Christopher E. Starr, MD
- Femtosecond Laser Cataract Surgery
A different option.
By Stephen G. Slade MD